These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 16298214)

  • 1. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study).
    Rothwell PM; Coull AJ; Silver LE; Fairhead JF; Giles MF; Lovelock CE; Redgrave JN; Bull LM; Welch SJ; Cuthbertson FC; Binney LE; Gutnikov SA; Anslow P; Banning AP; Mant D; Mehta Z;
    Lancet; 2005 Nov; 366(9499):1773-83. PubMed ID: 16298214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular disease of the heart, brain and limbs: new insights into a looming epidemic.
    Hankey GJ
    Lancet; 2005 Nov; 366(9499):1753-4. PubMed ID: 16298201
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronary event and case fatality rates in an English population: results of the Oxford myocardial infarction incidence study. The Oxford Myocardial Infarction Incidence Study Group.
    Volmink JA; Newton JN; Hicks NR; Sleight P; Fowler GH; Neil HA
    Heart; 1998 Jul; 80(1):40-4. PubMed ID: 9764057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Prognosis of Patients With Transient Ischemic Attack or Stroke and Symptomatic Vascular Disease in Multiple Arterial Beds.
    Heldner MR; Li L; Lovett NG; Kubiak MM; Lyons S; Rothwell PM;
    Stroke; 2018 Jul; 49(7):1639-1646. PubMed ID: 29880551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-Based Study of Incidence, Risk Factors, Outcome, and Prognosis of Ischemic Peripheral Arterial Events: Implications for Prevention.
    Howard DP; Banerjee A; Fairhead JF; Hands L; Silver LE; Rothwell PM;
    Circulation; 2015 Nov; 132(19):1805-15. PubMed ID: 26350058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of non-consensus transient ischaemic attacks with focal, negative, and non-progressive symptoms: population-based validation by investigation and prognosis.
    Tuna MA; Rothwell PM;
    Lancet; 2021 Mar; 397(10277):902-912. PubMed ID: 33676629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes.
    Bhatt DL; Peterson ED; Harrington RA; Ou FS; Cannon CP; Gibson CM; Kleiman NS; Brindis RG; Peacock WF; Brener SJ; Menon V; Smith SC; Pollack CV; Gibler WB; Ohman EM; Roe MT;
    Eur Heart J; 2009 May; 30(10):1195-202. PubMed ID: 19339264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PACIFIC (Prevention of AtherothrombotiC Incidents Following Ischemic Coronary attack) Registry: Rationale and design of a 2-year study in patients initially hospitalised with acute coronary syndrome in Japan.
    Miyauchi K; Morino Y; Tsukahara K; Origasa H; Daida H;
    Cardiovasc Drugs Ther; 2010 Feb; 24(1):77-83. PubMed ID: 20352313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study.
    Cotter G; Cannon CP; McCabe CH; Michowitz Y; Kaluski E; Charlesworth A; Milo O; Bentley J; Blatt A; Krakover R; Zimlichman R; Reisin L; Marmor A; Lewis B; Vered Z; Caspi A; Braunwald E;
    Am Heart J; 2003 Apr; 145(4):622-7. PubMed ID: 12679757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Younger vs Older Ages With Changes in Incidence of Stroke and Other Vascular Events, 2002-2018.
    Li L; Scott CA; Rothwell PM
    JAMA; 2022 Aug; 328(6):563-574. PubMed ID: 35943470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and Outcomes of Polyvascular (Coronary, Peripheral, or Cerebrovascular) Disease in Patients With Diabetes Mellitus (From the SAVOR-TIMI 53 Trial).
    Gutierrez JA; Scirica BM; Bonaca MP; Steg PG; Mosenzon O; Hirshberg B; Im K; Raz I; Braunwald E; Bhatt DL
    Am J Cardiol; 2019 Jan; 123(1):145-152. PubMed ID: 30366601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically recorded heart rate and incidence of 12 coronary, cardiac, cerebrovascular and peripheral arterial diseases in 233,970 men and women: A linked electronic health record study.
    Archangelidi O; Pujades-Rodriguez M; Timmis A; Jouven X; Denaxas S; Hemingway H
    Eur J Prev Cardiol; 2018 Sep; 25(14):1485-1495. PubMed ID: 29966429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute coronary syndromes in patients with prior cerebrovascular events: lessons from the Euro-Heart Survey of Acute Coronary Syndromes.
    Hasdai D; Haim M; Behar S; Boyko V; Battler A
    Am Heart J; 2003 Nov; 146(5):832-8. PubMed ID: 14597932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.
    Heart Protection Study Collaborative Group
    Lancet; 2002 Jul; 360(9326):7-22. PubMed ID: 12114036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low ankle-brachial index predicts an adverse 1-year outcome after acute coronary and cerebrovascular events.
    Agnelli G; Cimminiello C; Meneghetti G; Urbinati S;
    J Thromb Haemost; 2006 Dec; 4(12):2599-606. PubMed ID: 17002652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.
    Collins R; Armitage J; Parish S; Sleight P; Peto R;
    Lancet; 2004 Mar; 363(9411):757-67. PubMed ID: 15016485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Cerebrovascular and/or Peripheral Artery Disease With or Without Attainment of Lipid Goals on Long-Term Outcomes in Patients With Coronary Artery Disease.
    Volis I; Saliba W; Jaffe R; Eitan A; Zafrir B
    Am J Cardiol; 2020 Aug; 128():28-34. PubMed ID: 32650921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary disease and stroke in patients with large-vessel peripheral arterial disease.
    Criqui MH; Langer RD; Fronek A; Feigelson HS
    Drugs; 1991; 42 Suppl 5():16-21. PubMed ID: 1726213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
    Tran H; Anand SS
    JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.